Kowa Research Institute Inc.

4 trials 1 recruiting Commercial sponsor Merged from 2 name variants

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

1 Recruiting

3 Completed trials

4 Countries active

5 Unique IMPs

100% Results reported

Phase III

Phase II

Phase III/IV

Phase III: 2 Phase II: 1 Phase III/IV: 1

100%

3 of 3 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Corneal dystrophy 1

Top IMPs

RIPASUDIL 2 PEMAFIBRATE 1 PLATELET CONCENTRATE 1 TOFOGLIFLOZIN 1

All trials

4 total

Randomized, double-blind, parallel group clinical trial to evaluate the efficacy and safety of PRGF eye drops as a treatment for dry eye dis… Recruiting

2024-519460-40-00 Phase III/IV 1 country PLATELET CONCENTRATE
A Phase 2, Multicenter, Placebo-Controlled, Randomized, Double-Blind, 48-Week Study to Evaluate the Efficacy and Safety of Combination Thera… Ended

2023-508104-38-00 Phase II 2 countries PEMAFIBRATE; TOFOGLIFLOZIN
A Phase 3 Study to Investigate the Safety and Efficacy of Ripasudil (K-321) in Subjects with Fuchs Dystrophy Ended

2022-502643-35-00 Phase III 3 countries RIPASUDIL
A Study to Investigate the Safety and Effectiveness of Ripasudil (K-321) Eye Drops After Descemetorhexis in Subjects with Fuchs Endothelial … Ended

2024-511752-40-00 Phase III 3 countries RIPASUDIL

Showing 1–4 of 4 trials

← All sponsors A–Z